We also established a survival prediction model related to NOLC1 expression to predict the 2-year, 4-year, and 6-year survival rates of colorectal cancer, providing a basis for clinical diagnosis and treatment improvement. The gene discussed is NOLC1; the disease is colorectal cancer.